Lataa...
Cardio-renal protection with empagliflozin
Cardiovascular (CV) and kidney disease are common and significant complications in people with type 2 diabetes (T2DM). CV disease is the leading cause of death, morbidly and hospitalisations for people with T2DM. Furthermore, diabetic kidney disease is a major risk factor for CV disease and is the m...
Tallennettuna:
| Julkaisussa: | Ann Transl Med |
|---|---|
| Päätekijät: | , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
AME Publishing Company
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5107394/ https://ncbi.nlm.nih.gov/pubmed/27867961 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2016.10.36 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|